Tissue- vs iPSC-derived tumor organoids for cancer research
Organoid models for cancer research can largely be differentiated into two types: tissue-derived organoids and iPSC-derived organoids. In this infographic, part of our In Focus on organoids for cancer research, supported by Sartorius, we detail the differences in their preparation, the pros and cons of each type and provide key tips for their development and implementation.
This content was provided by
